Eczema on the scalp can cause hair loss, and the connection runs deeper than you might expect. Scratching inflamed skin is the most obvious culprit, but the immune dysfunction behind eczema also raises the risk of a separate hair-loss condition called alopecia areata. The good news is that most eczema-related hair loss is reversible once the underlying inflammation is brought under control, and treatments have expanded considerably in recent years.
How Scalp Eczema Damages Hair
When eczema (atopic dermatitis) flares on the scalp, inflammation disrupts the environment hair follicles need to function. The outer layer of skin loses moisture and its protective barrier weakens, leaving follicles exposed to irritants and allergens that intensify the cycle. Inflammatory signals flood the area, and the follicles can be pushed prematurely from their active growth phase into a resting phase, after which those hairs shed. Research on the scalp microbiome and hair-growth signaling has identified a shared pattern across several hair-loss conditions: barrier disruption, activation of the innate immune system, and impaired support of the growth phase all converge to stall healthy hair cycling.
Then there is the scratching. Eczema triggers an itch that can be almost impossible to ignore. Cytokines like IL-31 and IL-4/IL-13, along with neuropeptides such as substance P, create self-reinforcing itch-scratch loops that operate at the level of both the skin and the central nervous system.1PubMed Central. The Neuroimmune Axis in Atopic Dermatitis: From Pathogenic Mechanisms to Targeted Neuroimmunotherapy The more you scratch, the more the skin barrier breaks down, the more it itches, and the more mechanical damage the follicles sustain. Chronic scratching can physically uproot hairs, create tiny wounds that scar over time, and invite bacterial infection into already-compromised follicles. For people with scalp eczema, breaking this loop is often the single most important step in preventing further hair loss.
The Immune Link Between Eczema and Alopecia Areata
Some people with eczema develop patchy, often round bald spots that are not caused by scratching at all. This is alopecia areata, an autoimmune condition in which the immune system attacks hair follicles directly. Eczema and alopecia areata have long been observed together in clinical practice, and genetic research helps explain why. A systematic review and meta-analysis found that atopic dermatitis and several autoimmune diseases share immunologic pathways, and that genome-wide association studies have identified susceptibility genes for eczema that substantially overlap with genes linked to autoimmune conditions.2PubMed Central. Atopic dermatitis and risk of autoimmune diseases: a systematic review and meta-analysis
A more recent genetic analysis attempted to quantify this risk directly. Using data from large genome-wide association studies, researchers found that genetic variants linked to atopic dermatitis were associated with roughly an 84% increase in the risk of developing alopecia areata.3PubMed. Exploring the shared genetic mechanisms of atopic dermatitis and alopecia areata via bioinformatics approaches That does not mean everyone with eczema will develop alopecia areata, but it does mean the two conditions are not just coincidental neighbors. They share underlying immune wiring, and having one appears to genuinely raise the likelihood of the other.
Understanding this distinction matters for treatment. If you have eczema and notice well-defined patches of hair loss without much scaling or redness, that pattern fits alopecia areata better than simple eczema-related shedding, and it usually calls for a different therapeutic approach.
When Bacteria Compound the Problem
Eczema-affected skin is famously hospitable to Staphylococcus aureus, a bacterium that thrives when the skin barrier is broken. On the scalp, this is especially problematic because S. aureus does not just sit on the surface. Research has shown that S. aureus actively targets and enters hair follicles using specialized lipase enzymes, and once inside, it can invade the surrounding tissue.4PubMed Central. Staphylococcus aureus Enters Hair Follicles Using Triacylglycerol Lipases Preserved through the Genus Staphylococcus In eczema patients, S. aureus colonization correlates with disease severity, so the worse the eczema, the more the bacteria flourish, and the more inflammation they generate around the very structures producing your hair.
This creates a vicious cycle that sits on top of the itch-scratch loop already in play. Bacterial colonization intensifies the immune response, worsens the barrier breakdown, and can lead to secondary infections like folliculitis. If your scalp eczema seems persistently inflamed, oozes, or crusts over despite regular treatment, bacterial involvement is worth discussing with a dermatologist. Targeted antimicrobial measures, whether topical antiseptics or short courses of antibiotics, can sometimes be the missing piece that allows the scalp to calm down enough for hair to recover.
Hair Dyes and Contact Dermatitis on the Scalp
Not all scalp eczema is the atopic kind. Contact dermatitis, an allergic or irritant reaction triggered by something that touches the skin, can flare on the scalp after exposure to hair dyes, bleaches, or other styling products. Para-phenylenediamine (PPD), a chemical found in many permanent hair dyes, is one of the most common culprits. In one documented case, a woman experienced roughly 90% hair loss after using a PPD-containing dye, developing allergic contact dermatitis that led to widespread shedding.5PubMed Central. Severe Hair Loss of the Scalp due to a Hair Dye Containing Para phenylenediamine
That case is extreme, but subtler versions of the same reaction are more common than people realize. A study tracking patients after episodes of allergic contact dermatitis on the scalp found that half of them developed increased hair shedding two to four months later, consistent with a condition called telogen effluvium, in which a wave of follicles is pushed into the resting phase at once. In the affected patients, increased hair counts on pull tests and wash tests persisted at six months.6JAMA Dermatology. Telogen Effluvium After Allergic Contact Dermatitis of the Scalp The shedding is delayed because follicles do not fall out immediately when they enter the resting phase; they hang on for weeks before letting go, so you may not connect the hair loss to the product that caused it.
If you have eczema-prone skin and use hair dyes or chemical treatments, your barrier is already compromised, which can make you more susceptible to sensitization. Patch testing before using new products is worth the inconvenience, especially if you have ever noticed scalp itching, burning, or flaking after coloring your hair.
Topical Treatments for Scalp Eczema
The foundation of managing eczema-related hair loss is controlling the eczema itself. On the scalp, this means reducing inflammation and restoring the barrier so follicles can function normally again. Topical corticosteroids remain the first-line treatment for scalp eczema flares. They come in solutions, foams, and lotions that are easier to apply through hair than creams or ointments designed for other body areas. Short courses of medium- to high-potency topical steroids can bring acute flares under control quickly, though long-term continuous use raises concerns about skin thinning.
For people who need ongoing anti-inflammatory treatment or want to avoid prolonged steroid use, calcineurin inhibitors offer an alternative. Tacrolimus, applied as a solution to the scalp, has shown strong results in inflammatory scalp conditions. A study evaluating topical tacrolimus solution for inflammatory scalp disease found that over 95% of patients showed some degree of hair regrowth and reduction in inflammation after one month, with nearly three-quarters achieving excellent responses by two months.7PubMed Central. Tacrolimus in Solution as an Option to Inflammatory Conditions of the Scalp Unlike corticosteroids, tacrolimus does not cause skin thinning, making it a practical option for maintenance therapy on a sensitive area like the scalp.
Beyond prescription options, gentle scalp care makes a real difference. That means fragrance-free shampoos, minimal heat styling, and resisting the urge to scratch. Some people find that cool compresses or wet wraps on the scalp during flares help manage itch without mechanical damage to the follicles. Moisturizing the scalp can feel odd if you are used to thinking of moisturizers as face or body products, but barrier repair is as important on an eczema-affected scalp as anywhere else.
Biologic and Systemic Therapies
When scalp eczema is severe, or when eczema and alopecia areata coexist, topical treatments alone may not be enough. This is where newer systemic therapies enter the picture, and the overlap between eczema and hair-loss immunology has created some unexpected treatment opportunities.
Dupilumab, a biologic that blocks IL-4 and IL-13 signaling, is approved for moderate-to-severe atopic dermatitis and has shown promise in patients who also have alopecia areata. In one pediatric case, a child with severe alopecia areata and a history of eczema was treated with dupilumab combined with topical minoxidil; initial regrowth appeared by week seven, and the severity score dropped from 85% to about 9% by week thirty-seven.8PubMed Central. Dupilumab Combined with Topical 5% Minoxidil for Severe Alopecia Areata in a 2-Year-Old Child with Type 2 Immune Features: A Case Report In another pediatric case, dupilumab induced both hair regrowth and repigmentation of previously white hair, with black hair reaching about 90% of total hair density after seven injections at week twenty-eight.9PubMed Central. Hair repigmentation and regrowth in a dupilumab-treated paediatric patient with alopecia areata and atopic dermatitis: a case report However, that same case illustrated a significant limitation: four months after stopping dupilumab, the regrown hair fell out and white vellus hair returned. These are case reports, not large trials, so the evidence is still building, but they suggest that targeting the type 2 immune pathway can help a subset of patients whose eczema and alopecia areata share that immunologic driver.
JAK inhibitors represent another rapidly evolving category. Baricitinib and ritlecitinib have received regulatory approval specifically for alopecia areata in some countries, while upadacitinib is approved for atopic dermatitis. In a case of a 14-year-old with both alopecia universalis (complete body hair loss) and mild eczema, upadacitinib led to complete hair regrowth and resolution of eczema after three months of therapy.10PubMed Central. Alopecia Universalis in an Adolescent Successfully Treated with Upadacitinib-A Case Report and Review of the Literature on the Use of JAK Inhibitors in Pediatric Alopecia Areata The ability of JAK inhibitors to address both conditions simultaneously makes them especially appealing for patients dealing with the overlap. That said, these medications carry their own risk profiles, including potential effects on blood counts and lipid levels, so the decision to start one involves balancing severity of disease against side-effect monitoring.
Phototherapy for Resistant Cases
For people with alopecia areata who have not responded to other treatments, or who want to avoid systemic medications, phototherapy is sometimes offered. Narrowband UVB and excimer light are the two most commonly used forms. A study comparing local irradiation (targeting only the bald patches) with whole-body irradiation in alopecia areata patients, including those with the most severe form, found no significant difference in improvement rates between the two approaches.11PubMed Central. Efficacy of Local and Whole‐Body Phototherapy for the Treatment of Various Types of Alopecia Areata This suggests that for people with limited patches, targeted treatment can work just as well as treating the whole body, which is more convenient and exposes less skin to UV.
Phototherapy is generally considered safe for the scalp, but it requires multiple sessions over weeks to months, and the evidence base for alopecia areata specifically is thinner than for conditions like psoriasis. It tends to be used as an adjunct rather than a standalone treatment, often combined with topical therapies. For people whose hair loss is primarily driven by scalp eczema rather than autoimmune alopecia areata, phototherapy can also help by reducing the inflammatory component of the eczema itself.
Telling the Difference Between Types of Hair Loss
One of the trickiest parts of managing eczema-related hair loss is figuring out which type you are dealing with, because the treatment approach differs depending on the cause. Here are the common patterns:
- Eczema-driven shedding: Hair thins diffusely across inflamed areas. The scalp is red, flaky, or crusted. Hair typically regrows once the eczema is controlled.
- Alopecia areata: Smooth, round patches of bare skin without much scaling. The surrounding skin may look normal. This requires immune-targeted treatment rather than just eczema management.
- Telogen effluvium from contact dermatitis: Diffuse thinning that begins weeks to months after a scalp reaction, often from a hair product. The shedding is temporary but can be alarming in volume.
- Scarring from chronic scratching or infection: Permanent hair loss in areas of long-standing damage. The skin may look shiny or feel different in texture. Early intervention is critical because scarring cannot be reversed.
A dermatologist can usually distinguish these with a clinical exam, and sometimes a scalp biopsy or dermoscopy is needed to confirm. If you have eczema and are losing hair, getting the right diagnosis early makes a substantial difference in outcomes. Scarring hair loss in particular is a situation where delay costs you follicles that cannot come back.
Why Hair Usually Grows Back
If there is one reassuring thread running through the research, it is that most eczema-related hair loss is not permanent. Follicles pushed into a resting phase by inflammation will typically cycle back into growth once the inflammation resolves. Even in alopecia areata, the follicles are attacked but not destroyed; the immune assault puts them into a dormant state, which is why effective treatment can produce rapid and sometimes dramatic regrowth, as the case reports above illustrate.
The exception is scarring. When chronic inflammation, repeated infection, or years of aggressive scratching damage the follicle’s stem cell compartment, that follicle is gone. This is why dermatologists push for early and consistent treatment of scalp eczema even when it seems like a cosmetic nuisance. The window for preventing irreversible damage is wide in most people, but it is not infinite. Keeping inflammation controlled, managing the itch, avoiding harsh chemical exposures, and treating bacterial overgrowth when it occurs are all strategies that protect follicle health over time.
Scalp Microbiome and Emerging Research
One frontier worth watching is the role of the scalp microbiome. The community of bacteria and fungi living on your scalp influences inflammation, barrier function, and follicle health. Researchers have mapped out a three-tier signaling cascade in which microbial triggers at the surface activate inflammatory pathways in the middle tier, which in turn affect stem-cell activity, blood supply to follicles, and immune-privilege status deeper down.12PubMed Central. The Scalp Microbiome-Hair Axis: Mechanisms and Therapeutic Translation In eczema, the microbial balance is already disrupted, and on the scalp that disruption could be a missing piece in explaining why some people with eczema lose more hair than others with similar disease severity.
Malassezia, a yeast that is part of the normal scalp flora, plays a central role in seborrheic dermatitis and dandruff, and its overgrowth can worsen eczema symptoms on the scalp. The interplay between Malassezia, S. aureus, and the immune system is complex, and researchers are beginning to explore whether rebalancing the scalp microbiome through probiotics, targeted antimicrobials, or microbiome-friendly skincare could complement existing treatments. None of this is ready for clinical practice yet, but it reflects a shift toward understanding hair loss on eczema-affected scalps as an ecosystem problem rather than purely an immune one.